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Conclusion: The MC model of the linac revealed that CAX 
10x10cm2 PDDs are not very sensitive to changes in the mean 
energy of the incident electron beam. However 40x40cm2 
profiles reveal a high sensitivity to changes in the mean 
energy of the incident electron beam. The use of 10x10cm2 
CAX PDDs to match the mean energy of the incident electron 
beam can result in undesired differences between measured 
and calculated 40x40cm2 profiles. However using 40x40cm2 
profiles to match the mean energy of the incident electron 
beam can provide an overall better match to measurement of 
both PDDs and profiles. 
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Purpose or Objective: The large number of conventional 
electron accelerators on the market (we estimate it around 
5000) far exceeds the small, but growing number of mobile 
IORT linacs suitable for unshielded operating rooms. In this 
paper we discuss the technical aspects of the treatment 
beams produced by such small mobile IORT linacs. Beam 
parameter characterization for such machines need to be 
redefined in order to better reflect mobile IORT applications 
and provide basis for future technological development in the 
industry 
 
Material and Methods: Using currently accepted industry 
standards, we compared the following electron treatment 
parameters of conventional and IORT linacs. 
Treatment field size and shape 
Penetration depth 
Surface dose 
Beam Penumbra and Flatness 
Treatment on angular surface 
 
 
 
Results: The following key beam parameters are either not 
controlled at all for IORT, or controlled in a way that is not 
very clear and effective. Flatness of the beam: Not well 
defined.For the applicators 6 cm and below current flatness 
definition produces no sensible beam characterization.  
Penumbra: Not well defined. For beam sizes under 6 cm, the 
1 cm wide penumbra might lead to as much as 30% of the 
treatment volume being either underexposed, or “not 
properly accounted for” 
PDD drop off and Surface dose: Not controlled. PDD curve can 
change significantly as a function of field size and energy 
spectrum. An ideal monoenergetic beam has parameters 
which are not desirable in most IORT treatments. 
Effective treatment volume: Not defined or controlled. Very 
critical parameter. Ratio of the treatment volume with 
delivered dose above treatment threshold (e.g. 90%) to the 
nominal treatment volume can be as low as 30% if cold sports 
are not properly accounted for. 
Beveled applicator characteristics. Not defined or controlled. 
Procedures for testing of beveled applicators are very 
vaguely defined, and what definitions do exist are not very 
useful. 
 
 
 
Conclusion: In order to properly redefine critical IORT beam 
parameters we present newly defined parameters such as 
controlled Flatness, PDD drop off, Surface dose and Effective 
treatment volume. When defined and controlled, these 
parameters will allow engineering teams to optimize the 
parameters of the treatment devices and provide the 
superior beam characteristics to improve treatment 
results.We also propose unified beveled and oblong 
applicator measurement protocol to summarize the 
knowledge currently present in the field. 
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Purpose or Objective: The performance of the Portal 
Dosimetry (PD) used for pre-treatment verification is 
affected by the beam profile correction used in the MV 
imager dosimetry calibration. This study evaluates a simple 
method to improve the performance of the TrueBeam PD 
system. 
 
Material and Methods: A 40x40 cm2 diagonal profile 
measured at dmax is used as part of the imager calibration 
for the Portal Dosimetry software (PDIP). An over-response of 
the measured dose to predicted dose as the distance 
increases away from the central axis has been reported. 
Previous publications relating to the IDU20 panel have shown 
that manually modifying each point of the diagonal profile or 
applying software corrections can improve this off-axis 
effect. This method can be time consuming. A solution for 
the IDU20 panel with the Clinac model is available as part of 
the Varian Pre-Configured PDIP Package that utilizes an 
improved beam profile correction but is not currently 
available for the TrueBeam. The diagonal profile at d5 cm is 
almost identical with the profile at dmax up to about 10 cm 
and deviates downward as the distance increases. Using this 
profile for the calibration process could improve the off-axis 
areas of mismatch. The response of measured doses with 
predicted PDIP doses were evaluated in Varian TrueBeams 
equipped with either the IDU20 or the new DMI MV imaging 
panel. The PDIP algorithm was configured for use at 100 cm 
SDD following the manufacturer’s guidelines. Plans were 
created to compare the predicted with measured dose 
obtained by calibrating the imager at dmax and at d5 cm for 
6X and 10X. Open fields and complex fluence patterns were 
compared to those predicted by the PDIP to evaluate the 
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effect of the diagonal profile calibration in the dose 
measurements.  
 
Results: Measurements of open fields showed an over-
response (>3%) between measured and predicted doses at 
distances beyond 5 cm from CAX for IDU20 and beyond 10 cm 
from CAX for DMI calibrated with dmax profiles. Profile 
analysis for a 30x30 cm2 field IDU20 panel calibrated using 
the d5 diagonal profile showed an improved match (<3%) up 
to X=12 and Y=8 cm for 6X and up to X=13 and Y=9 cm for 
10X. The improvement for the DMI panel was up to 15 cm and 
14 cm for 6X and 10X, respectively, in both X and Y (Fig. 1)
 
 
The backscatter from the IDU20 panel is not corrected with 
this method and resulted in an increased discrepancy in the Y 
direction. For the DMI panel, which has reduced backscatter, 
the calibration with the d5 profile yielded an excellent match 
between predicted to measured dose. Furthermore, for the 
DMI panel, the open fields gamma analysis improved by up to 
5.3% for 6X and 15.2% for 10X. The test fluence patterns 
resulted in an improvement of up to 7.5% for 6X and 6.6% for 
10X (Table 1).  
 
 
 
Conclusion: The calibration of the imager panel using a 
diagonal profile at depth of d5 cm instead of the 
recommended depth of dmax resulted in an improved match 
between measured and predicted images for larger fields 
without affecting the results for smaller fields.  
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Purpose or Objective: We investigated the safety of 
Intrabeam™ system, X-ray unit for intraoperative 
RadoioTheray (IORT) by measuring surface dose using 
Optically Stimulated Luminescent Dosimeter(OSLD). 
 
Material and Methods: 30 patients were selected, who were 
in breast cancer patients and had an operation of breast 
conserving surgery (BCS). At the inner surface of tumor bed, 
20 Gy were described, and 5 Gy at 1cm depth from the inner 
surface. Along the the size of tumor bed which could be 
decided after resection of tumor, the size of applicator were 
determined. Usual treatment time were from 18 to 40 
minitutes. For the measurement of surface doses, OSLD were 
placed at superior (U1,2), inferior(D1,2), lateral(L1,2) and 
medial(M1,2) directions from the center of applicator. Each 
direction, two OSLD were placed at 0.5 cm and 1.5 cm from 
the center. Mean, maximum, and minimum doses were 
analyzed to be compared. 
 
Results: Mean values were U1 2.23±0.80 Gy, U2 1.54±0.53 
Gy, D1 1.73±0.63 Gy, D2 1.25±0.45 Gy, L1 1.95±0.82 Gy, L2 
1.38±0.42 Gy, M1 2.03±0.70 Gy, and M2 1.51±0.58 Gy. 
Maximum values were 4.34 Gy at U1, and Minimum values 
were 0.45 Gy at M2. 13.3 % of patient (4pts out of 30) were 
reported that surface dose were over 4 Gy. 
 
Conclusion: The fact that skin dose of all patients were less 
than 5 Gy based on OSLD measurement showed the safety of 
Intrabeam™ system. In the relatively small breast volume, 
the tendency that surface dose was increased had been 
shown, which was analyzed by the data of patients who 
irradiated over 4 Gy at skin surface. Therefore, for 
appropriate indication for IORT, it is suggested that breast 
volume as well as the size and position of tumor should be 
carefully considered. 
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Purpose or Objective: With daily image guided kV cone-
beam computed tomography (kVCBCT), dose to organs near 
the target can exceed 1 Gy during a treatment with 30 
fractions. Treatment with proton radiation reduces the dose 
outside the tumor, and reducing the dose from kVCBCT gets 
even more relevant. Reducing the dose from kVCBCTs can be 
done by shrinking the area that receive kVCBCT or lower the 
dose used for the uptake of kVCBCT. Prior study showed that 
the mAs used for kVCBCT can be greatly reduced without 
reducing the image quality (B. Loutfi-Krauss, 2015). This 
study have measured and compared the dose to organs at risk 
in children using different kVCBCT protocols. 
 
Material and Methods: The dose from kVCBCTs in the Varian 
TrueBeamTM accelerator were measured with 
thermolumenesence detectors (TLD), for lens, breast and 
gonads on CIRS anthromorphic children phantoms age 1, 5 
and 10 years.  
The kVCBCTs where performed with three different standard 
protocols: Head 1, Head 2, Thorax and Pelvis. In table 1 the 
settings for the different protocols can be seen.  
 
